Cargando…

Evaluation and correlation between SARS-CoV-2 neutralizing and binding antibodies in convalescent and vaccinated subjects

Since the first detection of a novel Coronavirus (SARS-CoV-2) in December 2019 in Wuhan (China), it has become crucial to assess and quantize the human humoral immune response after SARS-CoV-2 natural infection and/or vaccination. Having well standardized and reliable serological assays able to accu...

Descripción completa

Detalles Bibliográficos
Autores principales:	Manenti, Alessandro, Gianchecchi, Elena, Dapporto, Francesca, Leonardi, Margherita, Cantaloni, Paolo, Fattorini, Filippo, Piu, Pietro, Bollati, Valentina, Pastorino, Ugo, Apolone, Giovanni, Sozzi, Gabriella, Montomoli, Emanuele
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	The Authors. Published by Elsevier B.V. 2022
Materias:	Technical Note
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8619878/ https://www.ncbi.nlm.nih.gov/pubmed/34843712 http://dx.doi.org/10.1016/j.jim.2021.113197

Ejemplares similares

Timeline of SARS-CoV-2 Spread in Italy: Results from an Independent Serological Retesting
por: Montomoli, Emanuele, et al.
Publicado: (2021)

Antibody Avidity and Neutralizing Response against SARS-CoV-2 Omicron Variant after Infection or Vaccination
por: Dapporto, Francesca, et al.
Publicado: (2022)

Unexpected detection of SARS-CoV-2 antibodies in the prepandemic period in Italy
por: Apolone, Giovanni, et al.
Publicado: (2020)

SARS-CoV-2 Seroconversion and Pregnancy Outcomes in a Population of Pregnant Women Recruited in Milan, Italy, between April 2020 and October 2020
por: Accurti, Veronica, et al.
Publicado: (2022)

SARS-CoV-2 epidemiological trend before vaccination era: a seroprevalence study in Apulia, Southern Italy, in 2020
por: Marchi, Serena, et al.
Publicado: (2023)

Flow cytometry as an integrative method for the evaluation of vaccine immunogenicity: A validation approach
por: Gianchecchi, Elena, et al.
Publicado: (2023)

The neutralizing response to SARS-CoV-2 Omicron variants BA.1 and BA.2 in COVID-19 patients and homologous and heterologous vaccinees
por: Dapporto, Francesca, et al.
Publicado: (2022)

Evaluation of Monkeypox- and Vaccinia virus-neutralizing antibodies in human serum samples after vaccination and natural infection
por: Manenti, Alessandro, et al.
Publicado: (2023)

How to assess the effectiveness of nasal influenza vaccines? Role and measurement of sIgA in mucosal secretions
por: Gianchecchi, Elena, et al.
Publicado: (2019)

A serological investigation in Southern Italy: was SARS-CoV-2 circulating in late 2019?
por: Trombetta, Claudia Maria, et al.
Publicado: (2022)

SARS-CoV-2 escape from a highly neutralizing COVID-19 convalescent plasma
por: Andreano, Emanuele, et al.
Publicado: (2021)

SARS-CoV-2 escape in vitro from a highly neutralizing COVID-19 convalescent plasma
por: Andreano, Emanuele, et al.
Publicado: (2020)

Influenza vaccines: Evaluation of the safety profile
por: Trombetta, Claudia Maria, et al.
Publicado: (2018)

Neutralizing antibody against SARS-CoV-2 spike in COVID-19 patients, health care workers, and convalescent plasma donors
por: Zeng, Cong, et al.
Publicado: (2020)

Comparative analyses of SARS-CoV-2 binding (IgG, IgM, IgA) and neutralizing antibodies from human serum samples
por: Mazzini, Livia, et al.
Publicado: (2021)

Efficacy of mucosal vaccination using a protozoan parasite as a vehicle for antigen delivery: IgG and neutralizing response after rectal administration of LeCoVax-2, a candidate vaccine against COVID-19
por: Epis, Sara, et al.
Publicado: (2022)

Characterisation of SARS-CoV-2 Lentiviral Pseudotypes and Correlation between Pseudotype-Based Neutralisation Assays and Live Virus-Based Micro Neutralisation Assays
por: Hyseni, Inesa, et al.
Publicado: (2020)

Immunogenicity and Safety of the New Inactivated Quadrivalent Influenza Vaccine Vaxigrip Tetra: Preliminary Results in Children ≥6 Months and Older Adults
por: Montomoli, Emanuele, et al.
Publicado: (2018)

Yellow Fever: Origin, Epidemiology, Preventive Strategies and Future Prospects
por: Gianchecchi, Elena, et al.
Publicado: (2022)

Epidemic Preparedness—Leishmania tarentolae as an Easy-to-Handle Tool to Produce Antigens for Viral Diagnosis: Application to COVID-19
por: Varotto-Boccazzi, Ilaria, et al.
Publicado: (2021)

The theory and practice of the viral dose in neutralization assay: Insights on SARS-CoV-2 “doublethink” effect
por: Manenti, Alessandro, et al.
Publicado: (2021)

Cellular and Humoral Immune Responses and Breakthrough Infections After Two Doses of BNT162b Vaccine in Healthcare Workers (HW) 180 Days After the Second Vaccine Dose
por: Mangia, Alessandra, et al.
Publicado: (2022)

Comparing SARS-CoV-2 neutralizing antibody levels in convalescent unvaccinated, convalescent vaccinated, and naive vaccinated subjects
por: Dulipsingh, Latha, et al.
Publicado: (2023)

N. meningitidis and TLR Polymorphisms: A Fascinating Immunomodulatory Network
por: Gianchecchi, Elena, et al.
Publicado: (2016)

Sea buckthorn bud extract displays activity against cell-cultured Influenza virus
por: TORELLI, A., et al.
Publicado: (2015)

Evaluation of SARS‐CoV‐2 neutralizing antibodies using a CPE‐based colorimetric live virus micro‐neutralization assay in human serum samples
por: Manenti, Alessandro, et al.
Publicado: (2020)

Neutralizing antibodies in convalescent patients
por: Uhl, Lion F. K., et al.
Publicado: (2020)

The use of cell-mediated immunity for the evaluation of influenza vaccines: an upcoming necessity
por: Gianchecchi, E, et al.
Publicado: (2019)

Feasibility and Safety of Lung Cancer Screening and Prevention Program During the COVID-19 Pandemic
por: Milanese, Gianluca, et al.
Publicado: (2021)

SARS-CoV-2 Circulation during the First Year of the Pandemic: A Seroprevalence Study from January to December 2020 in Tuscany, Italy
por: Marchi, Serena, et al.
Publicado: (2022)

Influenza D Virus: Serological Evidence in the Italian Population from 2005 to 2017
por: Trombetta, Claudia M., et al.
Publicado: (2019)

Serological follow-up of SARS-CoV-2 asymptomatic subjects
por: Milani, Gregorio Paolo, et al.
Publicado: (2020)

Serologically-Based Evaluation of Cross-Protection Antibody Responses among Different A(H1N1) Influenza Strains
por: Marchi, Serena, et al.
Publicado: (2020)

Immune response to SARS-CoV-2 Omicron variant in patients and vaccinees following homologous and heterologous vaccinations
por: Trombetta, Claudia Maria, et al.
Publicado: (2022)

Effect of Repeated Freeze–Thaw Cycles on Influenza Virus Antibodies
por: Torelli, Alessandro, et al.
Publicado: (2021)

Combination Treatment with All-Trans Retinoic Acid Prevents Cisplatin-Induced Enrichment of CD133(+) Tumor-Initiating Cells and Reveals Heterogeneity of Cancer Stem Cell Compartment in Lung Cancer
por: Moro, Massimo, et al.
Publicado: (2015)

MicroRNA Profile of Lung Tumor Tissues Is Associated with a High Risk Plasma miRNA Signature
por: Fortunato, Orazio, et al.
Publicado: (2016)

Functional reprogramming of monocytes in patients with acute and convalescent severe COVID-19
por: Brauns, Elisa, et al.
Publicado: (2022)

Automated image-based assay for evaluation of HIV neutralization and cell-to-cell fusion inhibition
por: Sheik-Khalil, Enas, et al.
Publicado: (2014)

Nasopharyngeal Bacterial Microbiota Composition and SARS-CoV-2 IgG Antibody Maintenance in Asymptomatic/Paucisymptomatic Subjects
por: Ferrari, Luca, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_0tnq5qrcd21jmiu3ped8rpkc22